ROCHE BO27938 adjuvant trastuzumab emtansine vs trastuzumab

This study will evaluate the efficacy and safety of trastuzumab emtansine versus trastuzumab as adjuvant therapy in patients with breast cancer who have residual tumor present after neo-adjuvant therapy.

September 25, 2015